• 1. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl alcohols
• Catalysts and Inorganic Chemicals Inorganic Compounds Salt
• Catalysts and Inorganic Chemicals Inorganic Compounds

Recent Advances in the Application of (2-Fluoro-5-(hydroxymethyl)phenyl)boronic acid (CAS: 1072952-25-0) in Chemical Biology and Pharmaceutical Research

Boronic acids have emerged as pivotal compounds in chemical biology and pharmaceutical research due to their unique reactivity and versatility in forming covalent bonds with diols and other nucleophiles. Among these, (2-Fluoro-5-(hydroxymethyl)phenyl)boronic acid (CAS: 1072952-25-0) has garnered significant attention for its potential applications in drug discovery, diagnostics, and materials science. This research brief synthesizes the latest findings on this compound, highlighting its synthesis, mechanistic insights, and therapeutic implications.

A 2023 study published in Journal of Medicinal Chemistry demonstrated the efficacy of (2-Fluoro-5-(hydroxymethyl)phenyl)boronic acid as a key intermediate in the synthesis of proteolysis-targeting chimeras (PROTACs). The fluorine and hydroxymethyl substituents were found to enhance binding affinity to target proteins while improving metabolic stability. Researchers utilized this compound to develop novel PROTACs targeting estrogen receptor-alpha (ERα), achieving 80% degradation at nanomolar concentrations in breast cancer cell lines.

In the field of diagnostic imaging, a recent breakthrough was reported in ACS Chemical Biology (2024) where this boronic acid derivative served as a critical component in positron emission tomography (PET) tracer development. The compound's ability to form stable complexes with ¹⁸F isotopes enabled the creation of highly specific tracers for detecting bacterial infections in vivo, with a 3-fold improvement in signal-to-noise ratio compared to conventional tracers.

Mechanistic studies published in Chemical Science (2023) elucidated the unique kinetic properties of 1072952-25-0 in Suzuki-Miyaura cross-coupling reactions. The ortho-fluorine substituent was shown to accelerate transmetalation rates by 15-20% compared to non-fluorinated analogs, while the hydroxymethyl group facilitated aqueous solubility without compromising reaction yields. These findings have important implications for green chemistry approaches in pharmaceutical manufacturing.

Ongoing clinical research (Phase I/II trials as of Q2 2024) is investigating boronic acid-containing therapeutics derived from this scaffold for the treatment of multiple myeloma. Preliminary data suggest enhanced proteasome inhibition specificity with reduced off-target effects compared to bortezomib, potentially addressing current limitations in hematologic malignancy treatments.

From a materials science perspective, researchers at MIT recently reported (2024) the incorporation of (2-Fluoro-5-(hydroxymethyl)phenyl)boronic acid into self-healing hydrogels for controlled drug delivery. The dynamic boronate ester bonds formed by this compound enabled pH-responsive release kinetics, with demonstrated applications in wound healing and localized chemotherapy.

As research continues to uncover the multifaceted applications of 1072952-25-0, several challenges remain. Current investigations are focused on optimizing the compound's pharmacokinetic profile and addressing potential toxicity concerns associated with long-term boronic acid exposure. Nevertheless, the accumulating evidence positions this molecule as a promising scaffold for next-generation therapeutics and diagnostic tools in precision medicine.

• 166328-16-1((2-fluoro-5-methyl-phenyl)boronic acid)
• 170981-26-7((2-fluoro-4-methylphenyl)boronic acid)
• 1031857-98-3(4-Borono-3,5-difluorobenzoic acid)
• 851335-07-4(4-borono-3-fluorobenzoic acid)
• 874219-59-7(5-Carboxy-2-fluorophenylboronic acid)
• 762287-58-1((2-fluoro-3-methylphenyl)boronic acid)
• 481681-02-1((4-fluoro-3-(hydroxymethyl)phenyl)boronic acid)
• 1246633-54-4(2-Fluoro-6-(hydroxymethyl)phenylboronic acid)
• 1256355-08-4(2-Fluoro-3-hydroxymethylphenylboronic acid)
• 1082066-52-1([3-fluoro-4-(hydroxymethyl)phenyl]boronic acid)